Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Neuromyelitis Optica Spectrum Disorders · Myasthenia Gravis · Multiple Sclerosis · Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Autoimmune Encephalitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Huanhu Hospital, Tianjin, China
Contact: Study coordinator (Jialing Wu) · wywjl2009@hotmail.com · 86-18622271026
Study coordinator · tjzge@163.com
Contact: Principal Investigator (Jialing Wu)
Contact: Principal Investigator (Guanen Zhou)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Autoimmune Diseases · Autoimmune Diseases of the Nervous System · Neuromyelitis Optica Spectrum Disorder

Abroad (travel likely)RecruitingEARLY_PHASE1

Wuhan, China

Biomarkers in Autoimmune Disease of Nervous System

Autoimmune Diseases of the Nervous System · Neuromyelitis Optica Spectrum Disorder · Multiple Sclerosis

Abroad (travel likely)Recruiting

Wuhan, China

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Neuromyelitis Optica Spectrum Disorders (NMOSD) · Multiple Sclerosis · Autoimmune Encephalitis

Abroad (travel likely)Recruiting

Guangzhou, China

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Multiple Sclerosis (MS) · Neuromyelitis Optica Spectrum Disorder (NMOSD) · Autoimmune Encephalitis (AE)

Abroad (travel likely)RecruitingPHASE1

Wuhan, China